IVABRADINE
Zydus Lifesciences gets USFDA nod for generic heart failure treatment drugIvabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chroni...
Ind-Swift in stake sale talks with US companies to raise Rs 200 croreInd-Swift Laboratories is in talks with two leading US based firms for strategic stake sale to mop up Rs 200 crore, said sources.
- Load More